The cancer chemotherapy market continues to play a foundational role in oncology treatment, despite the rise of targeted therapies and immunotherapies. According to Business Market Insights, The cancer chemotherapy market size is expected to reach US$ 84,044.04 million by 2031 from US$ 39,509.70 million in 2024. The market is estimated to record a CAGR of 11.5% from 2025 to 2031. Cancer...

The cancer hormone therapy market is witnessing steady and significant growth, driven by the rising prevalence of hormone-sensitive cancers, advancements in targeted therapies, and increasing adoption of combination treatment approaches. According to Business Market Insights, the market was valued at USD 28.45 billion in 2025 and is expected to reach USD 48.65 billion by 2033, registering a...

The Cancer Radiation Therapy Market presents a strategically compelling and high-return set of Cancer Radiation Therapy Market Investment opportunities spanning AI-integrated adaptive radiation therapy systems, biology-guided radiotherapy platforms, proton therapy center development, emerging market radiotherapy infrastructure, targeted radionuclide therapy, and radiation oncology software and...

The cancer radiation therapy market is expanding rapidly, driven by the rising incidence of cancer, technological advancements in radiation delivery systems, and growing preference for non-invasive treatment options. According to Business Market Insights, the market was valued at USD 57.88 billion in 2024 and is expected to reach USD 136.16 billion by 2031, registering a strong CAGR of 13.00%...

The cancer targeted therapy market is witnessing exceptional growth, fueled by rapid advancements in precision medicine, biomarker discovery, and the increasing shift toward personalized cancer treatment. According to Business Market Insights, the market was valued at USD 95.12 billion in 2024 and is expected to reach USD 235.68 billion by 2031, registering a strong CAGR of 13.84% during the...

The cancer therapeutics market is experiencing robust and sustained growth, driven by the rising global cancer burden, rapid advancements in targeted therapies and immunotherapies, and increasing adoption of precision oncology. According to Business Market Insights, the market was valued at USD 142.8 billion in 2025 and is expected to reach USD 365.8 billion by 2033, registering a strong CAGR...